SpiroChem

🚀 𝐖𝐞 𝐚𝐫𝐞 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐨𝐮𝐫 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐰𝐢𝐭𝐡 𝐀𝐫𝐜𝐭𝐨𝐫𝐢𝐬! 🚀 Together, we’re launching an integrated drug discovery offering designed to streamline both biology and chemistry processes for biotechnology and pharmaceutical companies around the world. 🌎 This partnership brings together SpiroChem’s expertise in medicinal chemistry and enabling technologies with Arctoris' cutting-edge automated biology platform, Ulysses®. By combining our capabilities, we create a seamless path from hit identification to preclinical candidate selection, accelerating timelines and enhancing the quality of drug discovery projects. 🔬💡 → https://lnkd.in/evyBdZFX 𝐖𝐡𝐲 𝐭𝐡𝐢𝐬 𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐝 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐦𝐚𝐭𝐭𝐞𝐫𝐬: 🔹Enhanced data quality and reproducibility through automation  🔹Access to diverse chemical space and novel scaffolds  🔹Complete project support, scientific consulting, and logistics management 🔹Flexible, deliverable-based engagement model 𝐇𝐞𝐚𝐫 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐂𝐄𝐎, Thomas Fessard “Our partnership with Arctoris marks an important milestone, extending our chemistry expertise into a fully integrated discovery platform. With this joint offering, we are setting a new benchmark for innovation and efficiency in the pursuit of novel therapeutics." We’re excited to embark on this journey with Arctoris and to offer our clients the best chance of success in drug discovery. For more information, visit our website: → https://lnkd.in/evyBdZFX Gerhard Müller Tom Fleming Kinga Bercsenyi, PhD #DrugDiscovery #Pharmaceuticals #Biotechnology #Chemistry #Automation #Innovation #Partnership

📢 SpiroChem is proud to co-organize and sponsor the 15th Swiss Course on Medicinal Chemistry in Leysin, Swizerland, a five-day event gathering 90 participants and 30 speakers from industry and academia addressing the most relevant and exciting topics of drug discovery. The SpiroChem team will be represented by Dr. Gerhard Müller, SpiroChem’s CSO and co-organizer of the event, sharing his personal view on Medicinal Chemistry and providing a course overview during the opening evening. Dr. Quentin Lefebvre and Dr. David Pierrot will run a tutorial on the most modern approaches of synthetic medicinal chemistry. All the team is looking forward to meeting you there! #SpiroChem #Events #DrugDiscovery #MedicinalChemistry #SyntheticChemistry

📢 We are thrilled to be attending CPHI Europe 2024, a premier event celebrating 35 years of driving pharma innovation in Milan, Italy. Connect with our team and learn more about how SpiroChem’s Early PR&D group can help de-risk your projects. Roman Lagoutte, PhD (Director of Early PR&D), and Florent Beaufils, PhD (Chief Operating Officer), will be on site and eager to meet you. → Read more: https://lnkd.in/dtEudy4Y #SpiroChem #Events #PharmaInnovation #DrugDiscovery #CPHI2024

📢 We’re excited to announce that our CEO, Dr. Thomas Fessard, is currently attending Discovery on Target (DoT) 2024 in Boston! If you're at the conference or in the Boston area, don’t miss the opportunity to connect with Dr. Thomas Fessard and explore how SpiroChem can support and accelerate your drug discovery projects. #SpiroChem #Events #DrugDiscovery #DoT2024 #BostonDOT24

📢 Meet SpiroChem at 3 major events in October 2024! 📅 Our experts are excited to connect with you and share insights into the latest trends in covalent chemistries, synthetic biology, drug discovery, and more that can drive your projects forward! → Read more: https://lnkd.in/dtEudy4Y Connect with our team: Thomas Fessard, Gerhard Müller, Florent Beaufils, Roman Lagoutte, Quentin Lefebvre, David Pierrot, Daniel Elliott, Benoit Carbain, Raquel Mato and Laurence Jung #SpiroChem #Events #DrugDiscovery #MedicinalChemistry #Pharma #SyntheticBiology #CovalentChemistry

📢 We are thrilled to be returning to Boston for FBLD 2024, a great occasion to meet with experts from the fragment-based lead discovery community in chemistry and biochemistry in Boston, USA. Stop by our booth #14 or contact us to get an update on SpiroChem’s new integrated services to support your discovery programs: our CEO, Thomas Fessard, PhD, and our CSO, Gerhard Müller, PhD, will be on site all week. → Read more: https://lnkd.in/dN8ZxA7U #SpiroChem #Events #DrugDiscovery #FragmentBasedDrugDesign

Fragment-Based drug design (FBDD) has been widely adopted to efficiently find hits from relatively small sets of compounds. However, sp2-rich compounds are often overrepresented in commercial fragment libraries due to their ease of synthesis, sometimes leading to poor structural diversity and physical-chemical properties. In this paper just published in Synthesis, Special Topic Dedicated to Prof. Erick Carreira, SpiroChem demonstrates how “Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments”, by synthesizing 186 fragments with advantageous physical-chemical properties and covering a chemical space often neglected in traditional libraries. Full article available here: https://lnkd.in/eNya2WXF Thanks Quentin Lefebvre, Raquel Mato Santamaria and Colin Bournez for your great work! #ChemicalSpace #fragment #sp3 #HitFinding #FBDD #MedicinalChemistry

📢 SpiroChem will soon attend the XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024), taking place in Rome, Italy, from September 1-5, 2024. Meet our team at booth #35 to explore the latest innovations in medicinal chemistry and discuss how our cutting-edge solutions can accelerate your drug discovery efforts. Connect with our experts: Laurence Jung, Business Development Manager Florent Beaufils, Chief Operating Officer David Pierrot, Team Leader Christophe Salome, Group Leader, Medicinal Chemistry Division 🔗 Read more: https://lnkd.in/dN8ZxA7U #SpiroTeam #Events #MedicinalChemistry #DrugDiscovery #EFMCISMC2024

📢 Meet SpiroChem at 4 major events in September 2024! 📅 Our experts are eager to discuss the latest innovations and advancements in medicinal chemistry, medical oncology, computational drug design, and fragment-based lead discovery that could accelerate your projects! → Read more: https://lnkd.in/dN8ZxA7U Connect with our team: Thomas Fessard, Gerhard Müller, Laurence Jung, Florent Beaufils, David Pierrot, Christophe Salome, Serghei Chercheja, and Colin Bournez. #SpiroChem #Events #DrugDiscovery #MedicinalChemistry #Oncology #ComputationalChemistry #FragmentBasedDrugDesign

We're #hiring a new Research Chemist - Organic Synthesis in Basel. Apply today or share this post with your network.